![Karen Dawes](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Karen Dawes
Directeur/Membre du Conseil chez
BARINTHUS BIOTHERAPEUTICS PLC
Fortune : 12 M $ au 31/05/2026
Profil
Mme Karen T. Dawes est directrice indépendante de Vaccitech (UK) Ltd, directrice indépendante de PaxMedica, Inc. et présidente de Repligen Corp. et de Knowledgeable Decisions LLC. Elle siège au conseil d'administration de Vaccitech (UK) Ltd, PaxMedica, Inc, Medicenna Therapeutics Corp, Symbiomix Therapeutics LLC, Medicines 360, Seaside Therapeutics LLC et Vaccitech Plc. Mme Dawes a été précédemment employée en tant que directrice indépendante par Assertio Therapeutics, Inc, présidente par PDL BioPharma, Inc, vice-présidente principale et responsable du groupe commercial américain par Bayer Corp, vice-présidente principale par Wyeth Pharmaceuticals, Inc, directrice commerciale par Genetics Institute, Inc, vice-présidente du marketing par Pfizer Inc, et vice-présidente principale du marketing stratégique mondial par Wyeth Corp. Elle a également siégé au conseil d'administration d'Inspiration Biopharmaceuticals, Inc, de Protein Design Labs, Inc et de Genaissance Pharmaceuticals, Inc. Elle a obtenu son diplôme de premier cycle à l'université de Simmons, un diplôme d'études supérieures à l'université de Simmons et un MBA à l'université de Harvard.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
REPLIGEN CORPORATION 0,16 % | 14/05/2026 | 92 816 ( 0,16 % ) | 12 M $ | 31/05/2026 |
| 25/09/2025 | 45 224 ( 0,07 % ) | 14 110 $ | 31/05/2026 | |
| 06/03/2026 | 1 700 ( 0 % ) | 1 158 $ | 31/05/2026 |
Dernières actualités sur Karen Dawes
Postes actifs de Karen Dawes
| Sociétés | Poste | Début |
|---|---|---|
| REPLIGEN CORPORATION | Directeur/Membre du Conseil | 01/09/2024 |
| BARINTHUS BIOTHERAPEUTICS PLC | Directeur/Membre du Conseil | 01/03/2021 |
Vaccitech (UK) Ltd.
 Vaccitech (UK) Ltd. BiotechnologyHealth Technology Engages in research and experimental development on biotechnology | Directeur/Membre du Conseil | 17/02/2021 |
Medicines 360
 Medicines 360 BiotechnologyHealth Technology Conducts clinical trials, develops medicines, secures regulatory approvals, advocates, educates and expands availability to medicines | Directeur/Membre du Conseil | - |
Symbiomix Therapeutics LLC
 Symbiomix Therapeutics LLC BiotechnologyHealth Technology Develops medicines for prevalent gynecologic infections | Directeur/Membre du Conseil | 01/01/2013 |
Seaside Therapeutics LLC
 Seaside Therapeutics LLC Medical DistributorsDistribution Services Develops drug treatments to correct or improve the course of fragile x syndrome | Directeur/Membre du Conseil | - |
Knowledgeable Decisions LLC | Fondateur | 01/01/2003 |
Jones Public Affairs, Inc.
 Jones Public Affairs, Inc. Advertising/Marketing ServicesCommercial Services Provides advertising, public relations, marketing, advocacy and medical communication services | Directeur/Membre du Conseil | - |
Anciens postes connus de Karen Dawes
| Sociétés | Poste | Fin |
|---|---|---|
| MEDICENNA THERAPEUTICS CORP. | Directeur/Membre du Conseil | 12/02/2026 |
| ░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░░░░░░░░ ░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░ ░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Karen Dawes
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
62
Relations au 1er degré
22
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 22 |
|---|---|
Wyeth Corp.
 Wyeth Corp. Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes pharmaceuticals, vaccines & biotechnology products | Health Technology |
Genetics Institute LLC
 Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Protein Design Labs, Inc.
 Protein Design Labs, Inc. Pharmaceuticals: MajorHealth Technology Develops humanized monoclonal antibodies | Health Technology |
Repligen Corp.
 Repligen Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures biologic drugs | Health Technology |
Bayer Corp.
 Bayer Corp. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical, healthcare & agricultural products | Health Technology |
Assertio Therapeutics, Inc.
 Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Genaissance Pharmaceuticals, Inc.
 Genaissance Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops and uses genetic information to diagnostic and therapeutic products | Health Technology |
Inspiration Biopharmaceuticals, Inc.
 Inspiration Biopharmaceuticals, Inc. Medical SpecialtiesHealth Technology Produces intravenous recombinant therapies and develops non-invasive applications | Health Technology |
Symbiomix Therapeutics LLC
Symbiomix Therapeutics LLC BiotechnologyHealth Technology Develops medicines for prevalent gynecologic infections | Health Technology |
Simmons University
 Simmons University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PDL BioPharma, Inc.
 PDL BioPharma, Inc. BiotechnologyHealth Technology Operates as a pharmaceutical company that manufactures and wholesales prescription medicine products | Health Technology |
Knowledgeable Decisions LLC | |
Seaside Therapeutics LLC
Seaside Therapeutics LLC Medical DistributorsDistribution Services Develops drug treatments to correct or improve the course of fragile x syndrome | Distribution Services |
Jones Public Affairs, Inc.
Jones Public Affairs, Inc. Advertising/Marketing ServicesCommercial Services Provides advertising, public relations, marketing, advocacy and medical communication services | Commercial Services |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Medicines 360
Medicines 360 BiotechnologyHealth Technology Conducts clinical trials, develops medicines, secures regulatory approvals, advocates, educates and expands availability to medicines | Health Technology |
Medicenna Therapeutics Corp.
 Medicenna Therapeutics Corp. BiotechnologyHealth Technology Develops biopharmaceuticals | Health Technology |
Vaccitech (UK) Ltd.
Vaccitech (UK) Ltd. BiotechnologyHealth Technology Engages in research and experimental development on biotechnology | Health Technology |
Wyeth Pharmaceuticals, Inc.
 Wyeth Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
PaxMedica, Inc.
 PaxMedica, Inc. BiotechnologyHealth Technology Develops anti-purinergic therapies treatments for neurodevelopmental disorders | Health Technology |
Vaccitech Plc
 Vaccitech Plc Pharmaceuticals: MajorHealth Technology Discovers and develops immunotherapeutic products and vaccines for the treatment and prevention of infectious and cancer diseases | Health Technology |
